Kontigo Care Q2: Strong sales and 16% EBIT margin - Redeye

Redeye comments on Kontigo Care’s Q2’22 report where sales came in slightly higher than we estimated. The company continues to impress with solid revenue growth of 23% Y/Y and 8% Q/Q. This was the 9th consecutive report with net sales growth, continuing the solid growth path.

Länk till analysen i sin helhet: https://www.redeye.se/research/853734/kontigo-care-q222-strong-sales-and-16-ebit-margin?utm_source=finwire&utm_medium=RSS